Figure 4.

Neutralizing anti-TGF-β2 antibodies block TGF-β2 stimulated FPCL contraction. (A) Control and (B) disease FPCL cultures (± 1 ng/ml TGF-β2) were treated with the indicated concentrations of neutralizing anti-TGF-β2 antibodies. FPCL contraction was analyzed and plotted as the mean surface area ± SDM for quadruplicate cultures per treatment.

Tse et al. BMC Musculoskeletal Disorders 2004 5:41   doi:10.1186/1471-2474-5-41
Download authors' original image